Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock

被引:9
作者
Lee, Jae Ha [1 ]
Kim, Seong-Ho [2 ]
Jang, Ji Hoon [1 ]
Park, Jin Han [1 ]
Jo, Kyung Min [3 ]
No, Tae-Hoon [3 ]
Jang, Hang-Jea [1 ]
Lee, Hyun-Kyung [4 ]
机构
[1] Inje Univ, Coll Med, Dept Internal Med, Div Pulmonol & Crit Care Med,Haeundae Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea
[2] Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Rheumatol,Coll Med, Busan, South Korea
[3] Inje Univ, Coll Med, Dept Internal Med, Div Infect Dis,Hundae Paik Hosp, Busan, South Korea
[4] Inje Univ, Coll Med, Dept Internal Med, Div Pulmonol & Crit Care Med,Busan Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea
关键词
biomarkers; procalcitonin; prognosis; sepsis; septic shock; CAMPAIGN INTERNATIONAL GUIDELINES; PROCALCITONIN; PRESEPSIN; BACTEREMIA; MANAGEMENT; ACCURACY;
D O I
10.1097/MD.0000000000031895
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is a life-threatening condition and remains a major cause of mortality. The aim of this study was to evaluate the role of biomarkers in the diagnosis of sepsis and septic shock in patients admitted to the emergency department (ED). Medical records of patients who underwent measurement of serum biomarkers including lactic acid, C-reactive protein, procalcitonin (PCT), and presepsin in the ED between May 2019 and May 2020 were retrospectively reviewed. Patients were subdivided into 3 groups; non-sepsis, sepsis, and septic shock according to the new definition using the sequential organ failure assessment score. The mean age was 69.3 years, and 55.8% of the study population was female. Of 249 subjects, 98 patients confined to sepsis group, and 35.7% of them were septic shock. In the multivariable analysis, a high level of PCT was an independent predictor of sepsis (odds ratio [OR], 1.028; 95% confidence interval [CI], 1.006-1.051; P = .011) along with a simplified acute physiology score III (SAPS III) (OR, 1.082; 95% CI, 1.062-1.103, P < .001). PCT was also an independent risk factor for septic shock (OR, 1.043; 95% CI, 1.016-1.071, P = .02). In the receiver operating characteristic curve analysis, the area under the curve of PCT to predict sepsis and septic shock were 0.691 (P < .001) and 0.734 (P < .001), respectively. The overall 30-days mortality rate was 8.8%, and the mortality rate was significantly higher in the sepsis group (sepsis vs non-sepsis, 15.3% vs 4.6%; P = .004). In the multivariate Cox analysis, a higher level of lactic acid (hazard ratio [HR], 1.328; 95% CI, 1.061-1.663, P = .013), predisposing chronic pulmonary diseases (HR, 7.035; 95% CI, 1.687-29.341, P = .007), and a high SAPSIII value (HR, 1.046; 95% CI, 1.015-1.078, P = .003) were independent risk factors for mortality in sepsis patients. PCT was a useful biomarker for predicting sepsis and septic shock in the ED. A higher level of lactic acid, predisposing chronic pulmonary diseases, and a high SAPS III score were associated with a greater mortality risk in patients with sepsis.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock
    Brunkhorst, FM
    Wegscheider, K
    Forycki, ZF
    Brunkhorst, R
    INTENSIVE CARE MEDICINE, 2000, 26 (Suppl 2) : S148 - S152
  • [12] Emergency medicine updates: Evaluation and diagnosis of sepsis and septic shock
    Long, Brit
    Gottlieb, Michael
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2025, 90 : 169 - 178
  • [13] Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy
    Contenti, Julie
    Occelli, Celine
    Lemoel, Fabien
    Ferrari, Patricia
    Levraut, Jacques
    EMERGENCIAS, 2019, 31 (05): : 311 - 317
  • [14] The Prevalence and Clinical Significance of Low Procalcitonin Levels Among Patients With Severe Sepsis or Septic Shock in the Emergency Department
    Choe, Eun A.
    Shin, Tae Gun
    Jo, Ik Joon
    Hwang, Sung Yeon
    Lee, Tae Rim
    Cha, Won Chul
    Sim, Min Seob
    SHOCK, 2016, 46 (01): : 37 - 43
  • [15] Prognostic significance of the angiopoietin-2 for early prediction of septic shock in severe sepsis patients
    Duyen, Luu Thi Thanh
    Manh, Bui Van
    Thao, Tran Thi Phuong
    Khanh, Le Van
    Trang, Bui Ngoc Linh
    Giang, Ngo Truong
    Quang, Ha Van
    Viet, Nguyen Thanh
    Hang, Ngo Thu
    Mao, Can Van
    Toan, Nguyen Linh
    Tong, Hoang Van
    FUTURE SCIENCE OA, 2022, 8 (10):
  • [16] A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis
    D'Onofrio, Valentino
    Heylen, Dries
    Pusparum, Murih
    Grondman, Inge
    Vanwalleghem, Johan
    Meersman, Agnes
    Cartuyvels, Reinoud
    Messiaen, Peter
    Joosten, Leo A. B.
    Netea, Mihai G.
    Valkenborg, Dirk
    Ertaylan, Gokhan
    Gyssens, Inge C.
    JOURNAL OF INTENSIVE CARE, 2022, 10 (01)
  • [17] Severe Sepsis and Septic Shock: Timing of Septic Shock Onset Matters
    Huang, Chun-Ta
    Tsai, Yi-Ju
    Tsai, Pi-Ru
    Yu, Chong-Jen
    Ko, Wen-Je
    SHOCK, 2016, 45 (05): : 518 - 524
  • [18] Assessment of clinical sepsis-associated biomarkers in a septic mouse model
    Li, Jin-Ling
    Li, Ge
    Jing, Xi-Zhong
    Li, Yun-Feng
    Ye, Qiu-Ying
    Jia, Huan-Huan
    Liu, Shu-Hua
    Li, Xue-Jiao
    Li, Hang
    Huang, Ren
    Zhang, Yu
    Wang, Hui
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (06) : 2410 - 2422
  • [19] Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making
    Font, Michael D.
    Thyagarajan, Braghadheeswar
    Khanna, Ashish K.
    MEDICAL CLINICS OF NORTH AMERICA, 2020, 104 (04) : 573 - +
  • [20] Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis
    Valeriani, Emanuele
    Falletta, Antonio
    Pastori, Daniele
    Porfidia, Angelo
    Mastroianni, Claudio Maria
    Di Bari, Silvia
    Motta, Eleonora
    Pignatelli, Pasquale
    Oliva, Alessandra
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (09)